MRAP2
Melanocortin-2 receptor accessory protein 2
Also known as: bA51G5.2, C6orf117, MRAP2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96G30
- Gene
- MRAP2
- Ensembl
- ENSG00000135324
- Chromosome
- 6
- Canonical length
- 205 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted membrane proteins
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a protein that modulates melanocortin receptor signaling. The encoded protein has been shown to interact with all known melanocortin receptors and may regulate both receptor trafficking and activation in response to ligands. Mice lacking a functional copy of this gene exhibit severe obesity and a mutation in this gene may be associated with severe obesity in human patients. [provided by RefSeq, Oct 2016]
Canonical amino-acid sequenceUniProt
205 residues, UniProt reviewed canonical sequence.
>Q96G30|MRAP2
1 MSAQRLISNR TSQQSASNSD YTWEYEYYEI GPVSFEGLKA HKYSIVIGFW VGLAVFVIFM
61 FFVLTLLTKT GAPHQDNAES SEKRFRMNSF VSDFGRPLEP DKVFSRQGNE ESRSLFHCYI
121 NEVERLDRAK ACHQTTALDS DVQLQEAIRS SGQPEEELNR LMKFDIPNFV NTDQNYFGED
181 DLLISEPPIV LETKPLSQTS HKDLDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MRAP2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.69
- Highest tissue expression
- 97 nTPM
Expression across tissuesHPA
Tissue
- blood vessel: 97 nTPM
- hypothalamus: 15 nTPM
- cerebral cortex: 15 nTPM
- cerebellum: 14 nTPM
- choroid plexus: 8.4 nTPM
- spleen: 8.2 nTPM
Single-cell type
- pancreatic islet cells: 52 nCPM
- myosatellite cells: 48 nCPM
- other brain neurons: 46 nCPM
- gonadotrophs: 44 nCPM
- bergmann glia: 42 nCPM
- brain inhibitory neurons: 36 nCPM
Immune cell
- naive B-cell: 0.3 nTPM
- basophil: 0.1 nTPM
- neutrophil: 0.1 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
Brain region
- thalamus: 45 nTPM
- white matter: 34 nTPM
- hypothalamus: 31 nTPM
- cerebral cortex: 31 nTPM
- basal ganglia: 28 nTPM
- pons: 24 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about MRAP2.
Disease | AllUniProt
Conditions MRAP2 is implicated in, by any mechanism.
- Obesity (OBESITY) MIM:601665
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.88
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.31
- DepMap mean gene effect
- 0.08
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- energy homeostasis
- energy reserve metabolic process
- feeding behavior
- negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway
- negative regulation of protein localization to plasma membrane
- positive regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway
- protein localization to plasma membrane
- regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway
Molecular functions
- corticotropin hormone receptor binding
- identical protein binding
- signaling receptor regulator activity
- type 1 melanocortin receptor binding
- type 3 melanocortin receptor binding
- type 4 melanocortin receptor binding
- type 5 melanocortin receptor binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MRAP2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MRAP2 as an antibody target. Whether an autoantibody or antibody against MRAP2 could matter depends on whether native MRAP2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MRAP2 is annotated at the cell surface, where native MRAP2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label MRAP2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...